ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
22 announcements with these filters
Salem Erode Investments will hold a board meeting on November 12, 2026 to approve unaudited standalone results for the quarter and half-year. The notice is a prior intimation under Regulation 29.
Salem Erode Investments Ltd has filed its quarterly shareholding pattern under Regulation 31. This is a routine regulatory disclosure of share ownership structure.
ICL Fincorp and its PACs acquired 75,99,140 shares of Salem Erode Investments via a rights issue. The group's holding in diluted capital rose to 70.64%.
Salem Erode Investments Limited re-appointed Mr. Ambadath Aiyyappan Balan as a Non-Executive Independent Director for a term of 60 months.
Salem Erode Investments Ltd held its 95th Annual General Meeting on September 30, 2026. The meeting covered routine agenda items including financial statement adoption and director re-appointments.
Salem Erode Investments extended its rights issue closing date by six days to October 1. Revised allotment and listing dates shift to October 5 and 7 respectively.
Promoter ICL Fincorp renounced its rights entitlement in favour of 22 specific investors. They applied for up to 54,00,000 shares under the Rights Issue.
Salem Erode Investments Ltd. has scheduled its 95th Annual General Meeting for September 30, 2026, to be conducted via video conferencing.
Salem Erode Investments re-appointed Mr. Ambadath Aiyyappan Balan as an Independent Director for a five-year term. The board also convened its 95th Annual General Meeting for September 30, 2026.
Salem Erode Investments Ltd has fixed September 03, 2026, as the record date for its upcoming Rights Issue. The company has also announced the ISIN for rights entitlements.
Salem Erode Investments Ltd approved a rights issue of up to 1.15 crore shares at ₹20 per share, raising approximately ₹22.93 Crore.
Salem Erode Investments Limited approved a rights issue of 1.15 crore equity shares at ₹20 each, aggregating to ₹22.93 crore. The record date is September 3, 2026.
Salem Erode Investments will hold a board meeting on August 29, 2026, to determine the terms and conditions of its proposed rights issue.
Salem Erode Investments Ltd reported revenue from operations of ₹0.9 Cr (-18.2% YoY) and a net loss of ₹1.3 Cr for Q1 FY27.
Salem Erode Investments Ltd has scheduled a board meeting for August 13, 2026, to consider and approve the financial results for the quarter ended June 30, 2026.
Salem Erode Investments allotted 36,950 unlisted secured redeemable non-convertible debentures for ₹3.695 Crore on a private placement basis.
Salem Erode Investments Ltd board approved the issue of 40,000 unlisted non-convertible debentures on a private placement basis, aggregating to ₹4 Crore.
Salem Erode Investments Ltd has scheduled a Board Meeting for July 23, 2026, to consider raising funds through the issuance of Secured Redeemable Non-Convertible Debentures.
Salem Erode Investments approved the allotment of NCDs worth ₹0.92 Crore. These secured redeemable debentures were issued via private placement.
Salem Erode Investments Ltd reported revenue from operations of ₹0.7 Cr (-22.2% YoY) and a net loss of ₹1.4 Cr for Q4 FY26.
Salem Erode Investments reported its audited FY2026 financial results and re-appointed its internal and secretarial auditors. The board approved these outcomes during its May 2026 meeting.
Salem Erode Investments scheduled a board meeting for May 26, 2026. Directors will consider and approve audited standalone financial results for the 2026 fiscal year.